Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0002622 (
amnesia
)
5,520
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
It has been shown that a decrease in HMGs transcription factors phosphorylation by protein kinase CK2 may be the cause of a gene expression decline in cognitive disorders. Passive avoidance
amnesia
in old rats (24 month) was accompanied by a decrease in synaptosomal protein synthesis and transcription in isolated nuclei of cortex, hippocampus, and striatum. A decrease in chromatin protein kinase CK2 activity and a significant decrease in
HMG14
phosphorylation by CK2 was found in old rats. CK2 selective activators, a 4-carbamoyl-5-N-methylcarbamoyl-1-ethyl-imidazole and 4,5-dicaramoyl-1-ethyl-imidazole, produced the
HMG14
phosphorylation and transcription activation in old rats. At the same time, synaptosomal protein synthesis activation and passive avoidance
amnesia
reduction were observed in old rats. Thus, activation of CK2-
HMG14
was accompanied by synaptic plasticity optimisation. The data show a high therapeutic potential of activators of CK2-
HMG14
.
...
PMID:[State of the "protein kinase CK2-HMG14" system in age-dependent amnesia in rats]. 1213 29
Data on the nuclear cascade of signal transduction, including protein kinase CK2 (PKCK2), transcription factor
HMG14
and chromatin myosin-like proteins, are generalized with regard for the modern understanding of mechanisms of synaptic plasticity. The role of the neurospecific isoform and subunit structure of PKCK2, of the individual subunit autophosphorylation of PKCK2, of phosphorylation of substrate-proteins in the enzyme activity and of conformation transformations of chromatin is examined. Data on changes in the CK2-induced cascade and synaptic plasticity in learning, on age-related
amnesia
and on cognitive deficits induced by ethanol and chloridine in rat embryos are presented. The prospects for using modulators PKCK2, 4,5-di(N-methylcarbamoyl)-l-alkyl-imidazoles, as potential nootropics are discussed.
...
PMID:[Therapeutic potential of protein kinase CK2 modulators]. 1261 Nov 70
The experiments described here demonstrate that disruption of the phosphorylation of transcription factors of the HMG cAMP/Ca-independent protein kinase CK2 class may be the cause of decreased gene expression in age-related cognitive deficits.
Amnesia
for a conditioned passive avoidance reaction (CPAR) in aged rats (24 months old) was accompanied by decreases in the synthesis of synaptosomal proteins and transcription in nuclei isolated from cortical, hippocampal, and striatal neurons. There was a decrease in chromatin protein kinase CK2 activity and a significant decrease in the phosphorylation of
HMG14
by protein kinase CK2. Selective activators of protein kinase CK2 (1-ethyl-4-carbamoyl-5-methylcarbamoylimidazole and 1-ethyl-4,5-dicarbamoylimidazole) increased
HMG14
phosphorylation by protein kinase CK2, increased transcription, increased the synthesis of synaptosomal proteins, and decreased
amnesia
for the CPAR in aged rats. Thus, activation of the "protein kinase CK2-HMG14" system is accompanied by optimization of synaptic plasticity in aged animals. The results provide evidence for the high therapeutic potential of protein kinase CK2 activators.
...
PMID:Status of the "protein kinase CK2-HMG14" system in age-related amnesia in rats. 1463 96